Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DBF4 pseudogene 3 (DBF4P3) is a genomic sequence classified as a pseudogene, meaning it is a nonfunctional copy or derivative of the DBF4 gene. Unlike the functional DBF4 gene, which encodes a regulatory subunit for the CDC7 kinase and is essential for cell cycle progression and DNA replication[4][6], DBF4P3 does not produce a functional protein, has no known biological activity, does not participate in disease processes, and is not a target for pharmacological agents. It is important to distinguish DBF4P3 from the functional DBF4 gene. DBF4 is the regulatory subunit of the CDC7-DBF4 kinase, which is critical for DNA replication initiation and cell cycle progression and has established roles in cell proliferation and disease; however, DBF4P3, being a pseudogene, does not encode an active protein and is not considered a therapeutic target[4][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DBF4 pseudogene 3 (DBF4P3).